5.5
1상 생물변환 환원 반응은 환원을 통해 극성 작용기를 도입하거나 드러내어 약물을 변형하는 화학적 과정입니다. 환원효소라고 하는 효소는 이러한 반응을 촉매하여, 친유성 약물을 더 극성인 수용성 대사 산물로 전환하여 쉽게 배출되도록 하여 약물 대사에서 중요한 역할을 합니다…
환원 반응은 약물 분자에 전자를 도입하여 하이드록시 및 아미노와 같은 극성 작용기에 영향을 미쳐 후속 생체 내 변형 또는 접합을 가능하게 합니다.
카르보닐기 환원은 지방족 카르보닐 화합물과 방향족 및 지환식 케톤을 알코올로 변환합니다. 예를 들어, 날트렉손은 이소모르핀 유도체로 변형됩니다.
C=C 감소는, norethindrone 같이 스테로이드에서 보이는 것과 같이, 단 하나 결합으로 이중 결합을 개조합니다. 알코올은 환원 전에 알켄으로 탈수를 겪는데, 이는 경련 방지 약물 벤시클레인(bencyclane)의 대사 산물에 의해 예시됩니다.
N-화합물 환원은 니트로, 아조 및 N-산화물 그룹을 환원된 형태로 변환합니다. 예를 들어, 니트라제팜의 니트로 환원은 니트로소 및 하이드록실아민 중간체를 통해 진행되어 아민을 생성합니다.
아조 약물인 프론토실(Prontosil)은 활성 설파닐아미드(sulfanilamide)로 환원되는 반면, 이미프라민 N-옥사이드(imipramine N-oxide)는 이미프라민(imipramine)으로 전환됩니다.
기타 환원 반응은 약물 대사의 다양한 환원 과정을 포함합니다.
마취제 할로탄은 환원성 탈할로겐화를 거쳐 트리플루오로아세트산 또는 그 유도체로 전환됩니다.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main purpose of reductive reactions in drug metabolism?
Reductive reactions introduce electrons to drug molecules, modifying lipophilic drugs by introducing or revealing polar functional groups. Enzymes called reductases catalyze these reactions, transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. This process is essential for drug detoxification and elimination from the body.
Q2: How do carbonyl group reductions work in drug metabolism?
Carbonyl group reduction is an essential reductive reaction where aldehydes and ketones are reduced to alcohols. For example, naltrexone transforms into its isomorphine derivative through this process. Enzymes like aldehyde dehydrogenase catalyze the conversion of acetaldehyde to ethanol, demonstrating how carbonyl compounds are enzymatically reduced to their alcohol forms.
Q3: What happens to carbon-carbon double bonds during reductive drug metabolism?
Carbon-carbon double bonds are reduced to single bonds through enzymatic processes. Steroids like norethindrone undergo C=C reductions, converting their double bonds into single bonds. Enzymes like cytochrome P450 reductase catalyze these transformations, making drugs more water-soluble for subsequent biotransformation or conjugation.
Q4: How are nitro and azo compounds reduced during phase I metabolism?
Nitro groups are reduced to amino groups through nitroreductase enzymes, proceeding via nitroso and hydroxylamine intermediates. For instance, nitrazepam undergoes nitro reduction to yield an amine. Azo compounds like prontosil are reduced by azoreductases to active metabolites such as sulfanilamide, demonstrating how N-compounds transform during drug metabolism.
Q5: What role do N-oxide reductions play in drug biotransformation?
N-oxide reductions convert N-oxide groups to their reduced forms, representing an important class of reductive reactions. Imipramine N-oxide is converted to imipramine through this process. These reductions help modify drug structure and enhance water solubility, facilitating subsequent phase II conjugation reactions for drug elimination.
Q6: What are examples of miscellaneous reductive reactions in drug metabolism?
Miscellaneous reductive reactions encompass various reduction processes beyond carbonyl and double bond modifications. The anesthetic halothane undergoes reductive dehalogenation, converting to trifluoroacetic acid or its derivatives. These diverse reductive pathways demonstrate how different functional groups can be modified through enzymatic reduction to facilitate drug detoxification.
Q7: How do reductive reactions prepare drugs for subsequent biotransformation steps?
Reductive reactions introduce or reveal polar functional groups on drug molecules, creating reactive sites for subsequent biotransformation or conjugation. By converting lipophilic drugs into more polar, water-soluble metabolites, these reactions facilitate the action of phase II enzymes. This sequential modification process is critical for complete drug metabolism and efficient elimination from the body.